Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 3:56pm SGT - The Singapore stock market closes in 1 hour and 4 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
K V PHARMA CL A (KV-A)
At 5:02AM SGT:
3.03 USD
0.16 (5.02%)
MORE ON KV-A
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
K V PHARMA CL A
(NYSE:KV-A) Delayed quote data
Last Trade:
3.03 USD
Trade Time:
5:02AM SGT
Change:
0.16 (5.02%)
Prev Close:
3.19
Open:
3.19
Bid:
N/A
Ask:
N/A
1y Target Est:
1.00
Day's Range:
2.89 - 3.19
52wk Range:
0.58 - 5.36
Volume:
524,839
Avg Vol
(3m)
:
294,641
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add KV-A to Portfolio
Download Data
HEADLINES
Robbins Umeda LLP Announces Investigation of KV Pharmaceutical Company
Business Wire
(Fri, Jan 29)
KV PHARMACEUTICAL CO /DE/ Files SEC form 8-K, Other Events
EDGAR Online
(Fri, Jan 29)
Five Potential '10-Baggers' for Under $10
RealMoney by TheStreet.com
(Thu, Jan 28)
KV PHARMACEUTICAL CO /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
EDGAR Online
(Mon, Jan 11)
KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)
PR Newswire
(Mon, Jan 11)
KV PHARMACEUTICAL CO /DE/ Files SEC form 8-K, Other Events
EDGAR Online
(Fri, Jan 8)
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
PR Newswire
(Fri, Jan 8)
KV PHARMACEUTICAL CO /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
EDGAR Online
(Tue, Jan 5)
KV PHARMACEUTICAL CO /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online
(Thu, Dec 31)
KV PHARMACEUTICAL CO /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
EDGAR Online
(Wed, Dec 23)
More Headlines for KV-A...
ANALYST
EPS Est (next year)
(Mar-09)
:
N/A
EPS Est (in 2 years)
(Mar-10)
:
N/A
Avg Rec (current)*:
3.0
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
No business summary available for KV-A.
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices